LifePoint Health (LPNT) Misses Q3 EPS by 16c, Miss on Revenues; FY17 EPS/Revenue Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Lifepoint Holdings (LPNT) PT Lowered to $58 at Leerink Partners Following 3Q
October 31, 2017 8:35 AM EDTLeerink Partners lowered its price target on Lifepoint Holdings (NASDAQ: LPNT) to $58.00 (from $74.00) while maintaining a Outperform rating following the company's 3Q earnings report. The quarter was weak and LPNT's EBITDA margin expansion story was delayed due to physician referral issues impacting the 2016... More
Lifepoint Holdings (LPNT) PT Lowered to $54 at SunTrust Robinson Humphrey
October 30, 2017 8:14 AM EDTSunTrust Robinson Humphrey lowered its price target on Lifepoint Holdings (NASDAQ: LPNT) to $54.00 (from $60.00) while maintaining a Hold rating following a tough quarter.
... MoreLifepoint Holdings (LPNT) PT Lowered to $50 at Mizuho Securities
October 30, 2017 4:57 AM EDTMizuho Securities lowered its price target on Lifepoint Holdings (NASDAQ: LPNT) to $50.00 (from $58.00) while maintaining a Neutral rating.
Analyst Sheryl Skolnick is fearful as FCF turns negative noting the high capex causing the pressure is not set abate anytime soon. The analyst see LT... More
Raymond James Downgrades Lifepoint Holdings (LPNT) to Market Perform
October 30, 2017 4:55 AM EDTRaymond James downgraded Lifepoint Holdings (NASDAQ: LPNT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Lifepoint Holdings click here. For more ratings news on Lifepoint Holdings click here.
Shares of Lifepoint Holdings closed at $49.28 Friday.
... More